The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis.
- 1 December 1996
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 98 (11), 2436-2439
- https://doi.org/10.1172/jci119059
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Involvement of the Small GTPase Rho in Integrin-mediated Activation of Mitogen-activated Protein KinasePublished by Elsevier ,1996
- Integrin-mediated Activation of MEK and Mitogen-activated Protein Kinase Is Independent of RasPublished by Elsevier ,1996
- Ras Activation Is Necessary for Integrin-mediated Activation of Extracellular Signal-regulated Kinase 2 and Cytosolic Phospholipase A2 but Not for Cytoskeletal OrganizationJournal of Biological Chemistry, 1996
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Regulation of differentiated properties and proliferation of arterial smooth muscle cells.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Antagonistic effects of laminin and fibronectin on the expression of the myogenic phenotypeDifferentiation, 1989